Healthcare
Abingworth closes 10th fund on £225m
Life sciences and healthcare investor Abingworth has held a final close for Abingworth Bioventures VI on £225m, exceeding its £200m target.
CEA Investissement leads €2m round for Microphyt
CEA Investissement, Sofimac Partners and Soridec have taken part in a €2m funding round for Microphyt, a French biotech specialising in microalgae-based bioactive products.
Innovation Capital holds first close on €40m
Innovation Capital has held the first close for its Services Innovants Santé et Autonomie (SISA) fund, a vehicle aimed at the “silver economy”, on €40m.
NeoMed leads €15m round for InDex Pharmaceuticals
Venture capital firm NeoMed Management has led a €15m investment in Swedish drug developer InDex Pharmaceuticals via a new rights issue.
Percipient Capital backs Elucigene MBO
Percipient Capital has supported the management buyout of Elucigene Diagnostics, the UK-based arm of Hologic, a US-based healthcare diagnostics firm.
Beringea backs DCC with £3m
Beringea has invested £3m in Disposable Cubicle Curtains (DCC), a UK-based manufacturer of disposable curtains for hospitals that trades under All In One Medical.
Cinven, EQT target new geographies
European buyout houses Cinven and EQT have been looking further afield for healthcare investments, this week buying US-based CRO business Medpace and Australian radiology specialist I-Med, respectively.
Montagu acquires Dorc from Rabo Capital
Montagu Private Equity has acquired Dutch Ophthalmic Research Center (Dorc) from Rabo Capital, the private equity division of Rabo Bank.
Boehringer Ingelheim leads early-stage round for Amal
Boehringer Ingelheim Venture Fund (BIVF) and High-Tech Gründerfonds have invested in a seed-funding round for Swiss biotech start-up Amal Therapeutics.
Covagen extends series-B with Baxter investment
Swiss biotech Covagen has extended its CHF 42m series-B funding round, raised in December, to procure a further CHF 2.9m from Baxter Ventures.
GC Aesthetics enhanced with $60m investment
GC Aesthetics, a Dublin-based plastic surgery business, has secured a $60m investment from a consortium of investors.
Rosetta leads CHF 60m round for Novimmune
Life sciences-focused Rosetta Capital has led a CHF 60m ($66m) series-B funding round for Swiss biotech Novimmune.
HBM leads €41m round for AAA
HBM Healthcare Investments has led a €41m funding round for Advanced Accelerator Applications (AAA), a French biopharma company specialising in molecular nuclear medicine.
Deal in focus: uniQure raises $91.8m in IPO
Netherlands-based uniQure’s debut on the Nasdaq marks one of the latest in a string of European venture capital-backed biotechs flocking to the US markets, but the lack of activity in Europe's public markets does not necessarily equate to a slowdown...
North West Fund backs Fusion Implants
The North West Fund for Venture Capital, managed by Enterprise Ventures, has made a six-figure capital commitment to Fusion Implants, which manufactures veterinary implants using 3D printing technology.
Epidarex leads £4m investment in EMI
Epidarex Capital (formerly Rock Spring Ventures) has taken part in a £4m series-A funding round for Edinburgh University spinout Edinburgh Molecular Imaging (EMI).
VC-backed Egalet raises $50.4m in IPO
VC-backed UK pharma Egalet has raised $50.4m in its IPO on the Nasdaq, giving the company a market cap of $166.8m.
VC-backed Circassia to float on LSE
Circassia, a UK allergy treatment developer backed by several investors, has announced its plans to float on the London Stock Exchange (LSE) next month.
BerGenBio secures further NOK 75m
Norwegian oncology biopharma BerGenBio has raised a further NOK 75m (approximately $12.5m) from a syndicate of new and existing investors.
VC-backed uniQure raises $91.8m in IPO
Venture capital-backed Dutch gene therapy company uniQure raised well above its original expectation in its listing on the Nasdaq, bagging $91.8m.
PBM acquires Breas Medical
Healthcare-focused investor PBM Capital has acquired Breas Medical, a Sweden-based developer of sleep apnea treatment products, from General Electric subsidiary GE Healthcare.
VIYM invests in Semeiny Doktor
Russian firm Venture Investments & Yield Management (VIYM) has acquired a significant stake in Semeiny Doktor, a Russian chain of family medical clinics.
VC-backed Crossject to list on NYSE Alternext
French medical device company Crossject, backed by a consortium of local venture capital firms, is hoping to raise up to €12.9m in its IPO on the NYSE Alternext Paris.
YFM invests in Mangar
YFM Equity Partners has supported the management buyout of Mangar International, a provider of inflatable lifting, handling and bathing equipment for the elderly.